Bliss GVS Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE416D01022
  • NSEID: BLISSGVS
  • BSEID: 506197
INR
473.25
-3.85 (-0.81%)
BSENSE

Aug 10

BSE+NSE Vol: 5.56 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryBliss GVS Pharma VS Pharmaceuticals & Biotechnology
 
1D
-0.81%
0.06%
1W
1.62%
-0.12%
1M
-9.18%
1.25%
YTD
189.45%
-7.84%
1Y
166.39%
-1.65%
3Y
397.06%
19.57%
5Y
318.25%
43.97%
10Y
274.55%
182.78%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.31%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
75.7%
0.36%
76.06%
6 Months
128.18%
0.70%
128.88%
1 Year
166.39%
0.86%
167.25%
2 Years
319.55%
1.68%
321.23%
3 Years
397.06%
2.53%
399.59%
4 Years
515.01%
3.67%
518.68%
5 Years
318.25%
3.62%
321.87%

Latest dividend: 1.0062252964426877 per share ex-dividend date: Jul-08-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Bliss GVS Pharma Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-12.08%
1
Quartile
quartile-1
Mar-Jun
149.71%
1
Quartile
quartile-1
Dec-Mar
31.83%
1
Quartile
quartile-1
YTD
167.52%
2
Quartile
quartile-2
2025
-0.7%
3
Quartile
quartile-3
2024
32.14%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Bliss GVS Pharma Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-12.08%
1
Quartile
quartile-1
Mar-Jun
149.71%
1
Quartile
quartile-1
Dec-Mar
31.83%
1
Quartile
quartile-1
YTD
167.52%
1
Quartile
quartile-1
2025
-0.7%
3
Quartile
quartile-3
2024
32.14%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Good Performer

Bliss GVS Pharma Ltd has been in the First and Second Quartile in the YTD and longer periods

4
Quartile
quartile-4
QTD
-12.08%
1
Quartile
quartile-1
Mar-Jun
149.71%
1
Quartile
quartile-1
Dec-Mar
31.83%
1
Quartile
quartile-1
YTD
167.52%
2
Quartile
quartile-2
2025
-0.7%
2
Quartile
quartile-2
2024
32.14%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available